Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. W. (Wim) Timens

Publicaties

3D Culture of human lung fibroblasts decreases proliferative and increases extracellular matrix remodeling genes

Altered Extracellular Vesicle-Derived Protein and microRNA Signatures in Bronchoalveolar Lavage Fluid from Patients with Chronic Obstructive Pulmonary Disease

Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe COPD

Con: "Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?"

Context-specific eQTLs reveal causal genes underlying shared genetic architecture of critically ill COVID-19 and idiopathic pulmonary fibrosis

COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis

Lees meer

Pers/media

AI als multifocale bril van de patholoog

Longkanker: welke vorm heb ik?

Covid2019: ACE2-receptor speelde ook grote rol bij SARS.

Revival van de Dutch Hypothesis, in geïndividualiseerde vorm.

Pathologisch onderzoek essentieel voor kankerdiagnose

Kankercellen onder de loep

Zien welke kanker het is

PD-L1 kleuring vereist bij eerstelijnsbehandeling urotheelcarcinoom met pembrolizumab

Lees meer